Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic Syndrome - Wikidata - wikimedia - TriplyDB

Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic Syndrome

Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic Syndrome

http://www.wikidata.org/entity/Q29014175

about

Effect of Mukitake mushroom (Panellus serotinus) on the pathogenesis of lipid abnormalities in obese, diabetic ob/ob mice Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD Association between caffeine consumption and nonalcoholic fatty liver disease: a systemic review and meta-analysis Role of stem cells during diabetic liver injury Comorbidities and Metabolic Derangement of NAFLD Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis Metabolic syndrome: A review of the role of vitamin D in mediating susceptibility and outcome Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway Alanine aminotransferase-old biomarker and new concept: a review Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver Regulation of lipid stores and metabolism by lipophagy Role of receptor for advanced glycation end products (RAGE) in liver disease Fructose as a key player in the development of fatty liver disease High fat diet subverts hepatocellular iron uptake determining dysmetabolic iron overload Emerging role of microRNAs in liver diseases Metabolic investigations in patients with hepatitis B and C Amorfrutins are potent antidiabetic dietary natural products Nutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndrome Staphylococcal nuclease domain containing-1 (SND1) promotes migration and invasion via angiotensin II type 1 receptor (AT1R) and TGFβ signaling Autophagy in the liver: cell's cannibalism and beyond High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study Hyperferritinemia and hyperuricemia may be associated with liver function abnormality in obese adolescents Serum hepatic enzyme activity and alcohol drinking status in relation to the prevalence of metabolic syndrome in the general Japanese population Effect of diet on expression of genes involved in lipid metabolism, oxidative stress, and inflammation in mouse liver-insights into mechanisms of hepatic steatosis Association of liver enzymes and computed tomography markers of liver steatosis with familial longevity Liver Function Test Abnormalities in Depressed Patients Treated with Antidepressants: A Real-World Systematic Observational Study in Psychiatric Settings Impaired lung function is associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in middle-aged and elderly Chinese SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver Molecular mediators of hepatic steatosis and liver injury Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase.Low vitamin D status and obesity: Role of nutritionist.Effect of traditional Chinese medicine formula Sinisan on chronic restraint stress-induced nonalcoholic fatty liver disease: a rat study.What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis

P2860

Q21245690-0FA5F2AF-35E6-4551-976B-9272018BC9AD Q24564225-3E2CB4E1-A05D-43EB-B0C3-F6F7993AEE3C Q24625697-6B506531-5161-4652-BEBA-A6914A9AC7EF Q26738646-AF322F72-87DE-465F-A2EE-F89F3EA40AEF Q26746997-5CE414FA-5BDD-4E51-8C4D-ACCD59FEEB6D Q26752487-29C360AF-8CFC-410E-8271-0094D3D3938A Q26771874-690E98D7-1C3A-46F9-B579-7D4A94812ED6 Q26773551-1FC389F7-CC6E-4C54-8A4F-AA091B7F6BAC Q26777147-01E4FDF2-FCA2-47E5-934D-506BBD924132 Q26781477-037A4CCD-5BE1-40B7-98E4-E32465CCEB8A Q26798151-4D3CF384-1DC9-4A1F-8470-164343937FC5 Q26799612-55616608-538E-473F-BDE4-6AD059BD513E Q26800894-0DDBAA59-FC85-4DE7-BF80-B9B61DFCCBA6 Q26828819-78C0D885-DBAB-4736-9969-5AE2CFE9E4B2 Q26996539-8AE6A175-310E-44EE-95D1-52DC810EC48F Q27009151-8AF961C4-A962-457D-8812-B94310367218 Q27010462-1DFEEA14-28FC-4560-8272-38DC39D23051 Q27014596-87B298A2-931D-4705-BECF-A475685547AE Q27316857-0F968385-25AC-42D9-9A00-43D25976EBF0 Q27490492-622DA291-5011-4EA1-89D1-37247CF2BF3D Q27490887-A6660634-EFB0-4D65-9105-A7FD816760A5 Q27678567-3675C16F-6C50-4A3D-B436-1B6CC1B46DC5 Q28079661-14E4FE30-5DD3-42A1-AA72-B7595E7193CB Q28241756-D68100A2-79B5-451A-A58F-6027C90249BA Q28388115-90C9A3C9-66AB-4672-9259-CE57750EF5F3 Q28474831-24171408-7A32-4120-A90A-ADC8702D56FB Q28484682-684A49A2-86A2-4602-93B0-1A9FA423193A Q28538138-4AFB0BA2-AE85-4784-8FDF-401EEA55F282 Q28539815-C0526C10-4D38-466B-BB03-867EAC439B14 Q28540897-40E1D245-F4E4-460B-806B-81FE7454BCB6 Q28552027-577895FE-46EF-4E86-823A-5019E7ADA415 Q29248598-9E0C25B6-3CC7-491B-92F5-6613187A77B3 Q29547646-8A2C9F47-02A1-4CD4-B19E-B6D5FEB8A040 Q29616709-9DFF99EA-DBC5-49D5-93A0-7346A4BF693C Q29619334-E9EA78A2-F05B-4B94-8071-2046FC64278E Q30032295-B9FD1F85-86FA-4DFF-A54E-4D386CB3EA9D Q30235602-A3369F76-7D3C-4FB7-8725-D48DDF0EE397 Q30359021-8A157ED4-3065-4EFA-9666-F4FAE088B3BB Q30361645-124E1AA8-8D70-40AF-AF16-702FB24E4E94 Q30592294-D4901B0E-26A3-4993-8633-F5CB8B14212B

P2860

Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic Syndrome

http://www.wikidata.org/entity/Q29014175

description

2001 nî lūn-bûn

@nan

2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic Syndrome

@ast

Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic Syndrome

@en

type

label

Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic Syndrome

@ast

Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic Syndrome

@en

prefLabel

Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic Syndrome

@ast

Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic Syndrome

@en

P1433

Q29014175-DA1D4AE3-6E87-4E0D-B154-147B89083223

P1476

Q29014175-64C61914-A923-47F7-9127-BAE3CB92B388

P2093

Q29014175-01E05674-BB13-422D-99E0-6D71695F9D73

Q29014175-38FAFA2F-D06E-4E1F-9DCC-E968692EC73B

Q29014175-48C4DA46-90DF-4673-8A57-BBD2CC8D36AC

Q29014175-4D7D2A38-79B7-4FC3-AD6E-0FB8F34FB002

Q29014175-55F62963-ADF5-4EC9-AFB1-DEF7600D9668

Q29014175-6586DF8C-1AE8-4A9D-BCBA-CEE995A05A66

Q29014175-9FDD10FA-C466-46D3-8798-5CEAFCC80730

Q29014175-B8772FEC-22AF-4D08-B65A-A90B946F555C

Q29014175-D199E7B3-79FB-474B-9D5D-1C5B72E0DEDA

Q29014175-D9577945-FF80-4983-9BBF-39A4A7D61013

P304

Q29014175-E3EF32F1-8C82-4CE8-8252-7796BA902620

P31

Q29014175-3B49215D-2658-4A8A-BD2A-E81E6C800EDB

P3181

Q29014175-F2E2E24A-339C-470C-8518-42B28B59C8F4

P356

Q29014175-AD98A47D-690B-488C-8CBF-2DF81396879F

P407

Q29014175-529D2CED-6BB1-40E5-A292-A98AE8BB5B0B

P433

Q29014175-023E35D1-D76F-4DC6-B9AD-E5531012F445

P478

Q29014175-E6896DE3-6850-4A93-A7DF-1EE49BC6D8AE

P577

Q29014175-D3897779-1D16-4330-9FEF-74C222AACB80

P5875

Q29014175-362017CE-0D2A-41C4-B8D0-9320E667DF13

P698

Q29014175-133C33F9-5D5F-46FD-B3FC-F18A46EDC61E

P921

Q29014175-BB2342FD-186B-48AC-A4C5-AFFE0701B249

P3181

P356

DIABETES.50.8.1844

P1433

P1476

Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic Syndrome

@en

P2093

A. J. McCullough

http://www.w3.org/2001/XMLSchema#string

E. Bugianesi

http://www.w3.org/2001/XMLSchema#string

G. Bianchi

http://www.w3.org/2001/XMLSchema#string

G. Forlani

http://www.w3.org/2001/XMLSchema#string

G. Marchesini

http://www.w3.org/2001/XMLSchema#string

M. Brizi

http://www.w3.org/2001/XMLSchema#string

M. Lenzi

http://www.w3.org/2001/XMLSchema#string

N. Melchionda

http://www.w3.org/2001/XMLSchema#string

S. Natale

http://www.w3.org/2001/XMLSchema#string

S. Tomassetti

http://www.w3.org/2001/XMLSchema#string

P304

1844-1850

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

328994

http://www.w3.org/2001/XMLSchema#string

P356

10.2337/DIABETES.50.8.1844

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2001-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11869688

http://www.w3.org/2001/XMLSchema#string

P698

11473047

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome